MOTUS GI HLDGS INC

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch MOTS and buy or sell other stocks, ETFs, and their options commission-free!

About MOTS

Motus GI Holdings, Inc. is a medical technology company, which is dedicated to improving endoscopy outcomes and experiences. It engages in the development and commercialization of the Pure-Vu System to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. 

CEO
Timothy P. Moran
CEOTimothy P. Moran
Employees
30
Employees30
Headquarters
Fort Lauderdale, Florida
HeadquartersFort Lauderdale, Florida
Founded
2008
Founded2008
Employees
30
Employees30

MOTS Key Statistics

Market cap
11.01K
Market cap11.01K
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
379.59K
Average volume379.59K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.97
52 Week high$0.97
52 Week low
$0.215
52 Week low$0.215

Stock Snapshot

With a market cap of 11.01K, MOTUS GI HLDGS INC(MOTS) trades at $0.00.

On 2026-02-23, MOTUS GI HLDGS INC(MOTS) shares started trading at —, with intraday highs of — and lows of —.

Trading volume for MOTUS GI HLDGS INC(MOTS) stock has reached 0, versus its average volume of 379.59K.

The stock's 52-week range extends from a low of $0.22 to a high of $0.97.

The stock's 52-week range extends from a low of $0.22 to a high of $0.97.

People also own

Based on the portfolios of people who own MOTS. This list is generated using Robinhood data, and it’s not a recommendation.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.